L-Carnitine treatment in a child with valproic acid intoxication
Öz
Anahtar Kelimeler
Kaynakça
- 1.Sztajnkrycer MD. Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol. 2002; 40(6): 789-801.
- 2.Andersen GO, Ritland S. Life threatening intoxication with sodium valproate. J Toxicol Clin Toxicol. 1995; 33(3): 279-284.
- 3.Nau H, Loscher W. Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia. 1984; 25 Suppl 1:S14-22.
- 4.Lheureux PE, Penaloza A, Zahir S, Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care. 2005; 9(5): 431-40.
- 5.Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol (Phila). 2009; 47(2): 101-11.
- 6.Katiyar A, Aaron C. Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity. J Med Toxicol. 2007; 3(3): 129-38.
- 7.Ingels M, Beauchamp J, Clark RF, Williams SR. Delayed valproic acid toxicity: a retrospective case series. Ann Emerg Med. 2002;39(6): 616-21
- 8.Ghannoum M, Laliberté M, Nolin TD, MacTier R, Lavergne V, Hoffman RS, Gosselin S; EXTRIP Workgroup. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015; 53(5): 454-65.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Yoğun Bakım
Bölüm
Olgu Sunumu
Yazarlar
Ebru Kaçmaz
Bu kişi benim
0000-0002-7136-9441
Türkiye
Gürkan Bozan
0000-0001-5041-8892
Türkiye
Burak Özkan
Bu kişi benim
0000-0002-7738-9347
Türkiye
Sabiha Sahin
0000-0003-0759-4158
Türkiye
Yayımlanma Tarihi
15 Nisan 2021
Gönderilme Tarihi
25 Aralık 2020
Kabul Tarihi
4 Ocak 2021
Yayımlandığı Sayı
Yıl 2021 Cilt: 3 Sayı: 1